WADA releases frequently asked questions (FAQs) on Therapeutic Use Exemptions (TUEs)
27 September 2016 - As you know the cyber espionage group “Fancy Bear” has been releasing batches of confidential athlete data on their website, which they illegally obtained from a Rio 2016 Olympic Games account of the World Anti-Doping Agency (WADA)’s Anti-Doping Administration and Management System (ADAMS). Specifically, they are releasing data related to Therapeutic Use Exemptions (TUEs) delivered by Anti-Doping Organizations (ADOs) – International Federations (IFs), National Anti-Doping Organizations (NADOs), and Major Event Organizers (MEOs).
This situation has led to a lot of media coverage; and, unfortunately, a tremendous amount of misinformation as it relates to TUEs. It is very unfortunate that athletes’ TUEs are being debated publically on the basis of partial, confidential, medical information. Athletes should not be required to publically justify their TUEs.
This FAQ has been designed to address the misinformation and uphold the rights of clean athletes as embodied within the World Anti-Doping Code (Code) and the International Standard for Therapeutic Use Exemptions (ISTUE).
The TUE program is a rigorous and necessary part of elite sport; which has overwhelming acceptance from athletes, physicians and all anti-doping stakeholders worldwide.
Click here to read the FAQ document.
- Anti-Doping International Standard for Therapeutic Use Exemptions (ISTUE) Therapeutic Use Exemption (TUE) World Anti-Doping Agency (WADA) World Anti-Doping Code (WADC)